Why Capricor Therapeutics Stock Is Soaring Tuesday

Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a biologics license application (BLA) for the full approval of Deramiocel for the treatment of Duchenne muscular dystrophy cardiomyopat…